HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver.

Abstract
Emerging evidence suggests that the lack of PPARα enhances hepatic steatosis and inflammation in Ppara-null mice when fed a high-fat diet (HFD). Thus, the aim of this study was to determine whether Ppara-null mice are more susceptible to nonalcoholic steatohepatitis (NASH) than their wild-type (WT) counterparts following short-term feeding with a HFD. Age-matched male WT and Ppara-null mice were randomly assigned to consume ad libitum a standard Lieber-DeCarli liquid diet (STD) (35% energy from fat) or a HFD (71% energy from fat) for 3 wk. Liver histology, plasma transaminase levels, and indicators of oxidative/nitrosative stress and inflammatory cytokines were evaluated in all groups. Levels of lobular inflammation and the NASH activity score were greater in HFD-exposed Ppara-null mice than in the other 3 groups. Biochemical analysis revealed elevated levels of ethanol-inducible cytochrome P450 2E1 and TNFα accompanied by increased levels of malondialdehyde as well as oxidized and nitrated proteins in Ppara-null mice. Elevated oxidative stress and inflammation were associated with activation of c-Jun-N-terminal kinase and p38 kinase, resulting in increased hepatocyte apoptosis in Ppara-null mice fed a HFD. These results, with increased steatosis, oxidative stress, and inflammation observed in Ppara-null mice fed a HFD, demonstrate that inhibition of PPARα functions may increase susceptibility to high fat-induced NASH.
AuthorsMohamed A Abdelmegeed, Seong-Ho Yoo, Lauren E Henderson, Frank J Gonzalez, Kimberley J Woodcroft, Byoung-Joon Song
JournalThe Journal of nutrition (J Nutr) Vol. 141 Issue 4 Pg. 603-10 (Apr 01 2011) ISSN: 1541-6100 [Electronic] United States
PMID21346097 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Dietary Fats
  • PPAR alpha
  • Proteins
  • Tumor Necrosis Factor-alpha
  • Cytochrome P-450 CYP2E1
  • Nitric Oxide Synthase Type II
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Apoptosis
  • Cytochrome P-450 CYP2E1 (analysis)
  • Dietary Fats (administration & dosage)
  • Fatty Liver (pathology, prevention & control)
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • Lipid Peroxidation
  • Liver (pathology)
  • Male
  • Mice
  • Nitric Oxide Synthase Type II (analysis)
  • Non-alcoholic Fatty Liver Disease
  • Organ Size
  • PPAR alpha (physiology)
  • Proteins (metabolism)
  • Tumor Necrosis Factor-alpha (analysis)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: